Dr. Berger co-founded Sciadonics, Inc. to commercialize SCI and other special fatty acids, with the goal of reducing our rampant chronic inflammation. As SCI can be used alone or in combination with- other nutritional oils (such as fish oil), anti-oxidants, and drugs, to combat chronic- and diverse forms of inflammation and associated symptoms (pain, discomfort, etc.), the market opportunity is enormous. Moreover, SCI can be added to food vehicles requiring a longer shelf life, a particular challenge for fish oils. Dr. Berger and colleagues have painstakingly identified seeds and other sources of SCI and related fatty acids that are economical, abundant, with a history of safe use, and protected by our intellectual property.